Genetic Technologies Ltd. - notizie pubblicate 153 - letture 1.766
GENETIC TECHNOLOGIES LTD.
Appendix 4C & Quarterly Business Update – June 2024 Form 6 K
Appendix 4c & quarterly business update - june 2024 restructuring to focus on dtc and u.s. sales growth melbourne, australia, 31 july 2024: genetic technologies limited (asx:gt ...
GENETIC TECHNOLOGIES LTD.
Strategic restructure to focus on USA sales growth Form 6 K
Strategic restructure to focus on usa sales growth melbourne australia, july 26, 2024: genetic technologies limited (asx: gtg; nasdaq: gene, "company", "gtg"), ...
GENETIC TECHNOLOGIES LTD.
Resignation of Chief Financial Officer and Company Secretary Form 6 K
Resignation of chief financial officer and company secretary melbourne, australia, june 28, 2024: genetic technologies limited (asx: gtg; nasdaq: gene, "company", "g ...
GENETIC TECHNOLOGIES LTD.
Business Update Form 6 K
The text version of this document is not available. you can access the original document here. attachments original link original document permalink disclaimer genetic technologies ...
GENETIC TECHNOLOGIES LTD.
Join Genetic Technologies’ Exclusive Live Investor Webinar and Q&A Session on June 27 Form 6 K
Join genetic technologies' exclusive live investor webinar and q&a session on june 27 melbourne, australia - june 21, 2024 - genetic technologies limited (asx:gtg; nasdaq:gene, ...
GENETIC TECHNOLOGIES LTD.
GeneType and Stayhealthy Announce Landmark Distribution Agreement for Revolutionary Multi Risk Test Form 6 K
Genetype and stayhealthy announce landmark distribution agreement for revolutionary multi-risk test melbourne, australia, june 5, 2024: genetic technologies limited (asx: gtg; nasd ...
GENETIC TECHNOLOGIES LTD.
GTG Launches Revolutionary geneType Test covering 100% Risk of Breast and Ovarian Cancer - Form 6-K
Gtg launches revolutionary genetype test covering 100% risk of breast and ovarian cancer melbourne, australia, may 29, 2024: genetic technologies limited (asx: gtg; nasdaq: gene, & ...
GENETIC TECHNOLOGIES LTD.
Notice of Effectiveness - Form EFFECT
Notice of effectiveness united states securities and exchange commission washington, d.c. 20549 notice of effectiveness effectiveness date: may 24, 2024 5:00 p.m. form: f-1 cik: 00 ...
GENETIC TECHNOLOGIES LTD.
Registration Statement by Foreign Issuer - Form F-1
As filed with the securities and exchange commission on may 17, 2024 registration no. 333- united states securities and exchange commission washington, d.c. 20549 form f-1 registra ...
GENETIC TECHNOLOGIES LTD.
GTG and ‘Wellworks for You’ sign B2B sales & marketing deal covering 750 employer groups and 2 million U.S. employees - Form 6-K
Gtg and 'wellworks for you' sign b2b sales & marketing deal covering 750 employer groups and 2 million u.s. employees. melbourne, australia, may 6, 2024: genetic technologies l ...
GENETIC TECHNOLOGIES LTD.
Launching our most comprehensive test and expanding into new global markets - Form 6-K
Launching our most comprehensive test and expanding into new global markets melbourne, australia, 30 april 2024: genetic technologies limited (asx:gtg; nasdaq:gene, "company&q ...
GENETIC TECHNOLOGIES LTD.
Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities - Form 6-K
The text version of this document is not available. you can access the original document here. attachments original link original document permalink disclaimer genetic technologies ...
GENETIC TECHNOLOGIES LTD.
Genetic Technologies Announces Closing of US$2 Million Registered Direct Offering - Form 6-K
Genetic technologies announces closing of us$2 million registered direct offering melbourne, australia, april 23, 2024 / genetic technologies limited (asx:gtg; nasdaq:gene, "c ...
GENETIC TECHNOLOGIES LTD.
Cleansing Notice under section 708A of the Corporations Act 2001 (Cth) - Form 6-K
Cleansing notice under section 708a of the corporations act 2001 (cth) on 19 april 2024 genetic technologies limited acn 009 212 328 (asx: gtg; nasdaq: gene) (the company) announce ...
GENETIC TECHNOLOGIES LTD.
Appendix 2A - Application for quotation of securities - Form 6-K
The text version of this document is not available. you can access the original document here. attachments original link original document permalink disclaimer genetic technologies ...
Sei un professionista?
Abbiamo ricevuto 2.400 richieste di consulenza, pubblica il tuo profilo premium
per ricevere contatti e acquisire nuovi clienti